- Second Chance AIHA ›
- Forums ›
- AIHA Dog ›
- Hector
Clara,
I am not sure why she responded this way. Is it possible she has discontinued this protocol? There is no question she asked me to use it for Chance, I have the protocol she sent me in front of me and the emails between us discussing how to do this.
“Pulse therapy means the administration of large doses of drugs in an intermittent manner to enhance the therapeutic effect and reduce the side effects. ”
Certain treatments, like cancer protocols or prednisone are given this way.
Here is the section in the protocol she sent to me in 2007:
Immune-mediated Hematological Disease and Bone Marrow Failure
W. Jean Dodds, DVM HEMOPET
snip>”For severe cases, other immunosuppressive therapy is given. We prefer cyclosporine (Atopica, or Neoral, or Sandimmune, 100 mg/ml oral syrup) instead of cyclophosphamide (Cytoxan) and give it at 10 mg/kg for 5 days rest 2 days, then at 5mg/kg for another 5 days. The lower dose is repeated after a 2 day rest on a 5 days on, 2 days off cycle as long as is needed (usually 2-3 courses of 5 days). This drug induces rapid T-cell suppression within about 48 hours and has been safe, effective, and well-tolerated at these doses.”
Clara,
I found a number of references that discuss pulse dosing or “pulsatile drug delivery” that are used in specific treatment protocols. Here is just one that is actually referring to delivering drugs in a pulsed dose.
Journal of Drug Delivery and Therapeutics
PULSATILE DRUG DELIVERY AS MODIFIED RELEASE DOSAGE FORM : A REVIEW
“Pulsatile drug delivery is a advanced drug delivery system in pharmaceutical field. Pulsatile system is one of the modified release dosage form system and gaining a lot of interest as it is increasing patient compliance by means of providing time- and site-specific drug delivery system. Pulsed or pulsatile drug release is defined as the rapid and transient release of a certain amount of drug molecules within a short time-period immediately after a predetermined off-release period.”
my best
patrice
- This reply was modified 10 years, 2 months ago by Patrice.
Initial info from Jean:
Generic Advice : In addition to any medications he is taking already, we give thyroxine routinely at a conservative dose to stimulate the bone marrow to make new RBCs—regardless of the thyroid activity levels of the dog. The dose of thyroxine is 0. 1 m g per 15 pounds of optimum weight twice daily. Give it at least an hour before or three hours after any food containing calcium or soy, to ensure absorption.
IF the PCV cannot be maintained at or above 22-25%, then the other drug we use, in addition to cyclosporine (Atopica, Neoral) azathioprine, and prednisone — is adding mycophenolate (Cell Cept). But we generally do not recommend Arava (leflunomide) as it can cause adverse effects on the liver. Anabolic steroids can also be considered (decadurabolin) .
For his liver, he needs to eat a gluten-free diet (no wheat, corn or soy) in 3-4 smaller meals a day, and receive liver cleansing herbs (milk thistle, SAMe). To help stimulate the bone marrow we use a hematinic like Pet-Tinic (Zoetis/Pfizer) or Hi-Vite. Regarding his diet, the attached home cooked liver cleansing diet is preferred (3 smaller gluten-free meals daily); can substitute chicken , turkey or pork, if he doesn’t like white colored fish.
IMMUNE-MEDIATED HEMATOLOGIC DISEASE AND BONE MARROW FAILURE
W. Jean Dodds, DVM
HEMOPET
938 Stanford Street
Santa Monica, CA 90403
(310) 828-4804 Fax (310) 453-5240
Immune-mediated hematologic disease is being reported with increasing frequency in animals and humans. In the dog this syndrome is often associated with bone marrow failure. Affected animals usually have one or more of the following signs: autoagglutinating red blood cells; Coombs positive hemolytic anemia; spherocytes; nonregenerative or poorly regenerative erythroid response; severe thrombocytopenia; profound leukopenia; other autoimmune diseases especially thyroiditis; active erythrogenesis, granulocytopoiesis or megakaryocytopoiesis with maturation arrest at the early stem cell level; and poor response to standard treatment protocols with corticosteroids and other immunosuppressive drugs. In many cases a recent stress (e.g. vaccination; drug; chemical or toxic exposure; surgery; hormonal influence; infection; injury) could be identified as a potential triggering event within the previous 30 days.
Our experiences with these cases indicate that:
1) Autoimmune thyroiditis/hypothyroidism is frequently present and/or affected dogs are often of breeds or cross-breeds susceptible to thyroid disease.
2) Aggressive and more sustained treatment with corticosteroids is needed. Suggested doses are: Prednisone or prednisolone given at 2-3 mg/lb/day divided BID for 5-7 days, or dexamethasone equivalents at 0.25-0.35 mg/l b/day divided BID. Therapy is reduced weekly by 1/2 and maintained for at least six weeks. Alternate day steroid therapy may be needed for some time thereafter on a longterm, low level basis.
3) For severe cases, other immunosuppressive therapy is given. We prefer cyclosporine (Sandimmune, 100 mg/ml oral syrup) instead of cyclophosphamide (Cytoxan) and give it at 10 mg/kg for 5 days rest 2 days, then at 5mg/kg for another 5 days. The lower dose is repeated after a 2 day rest on a 5 days on, 2 days off cycle as long as is needed (usually 2-3 courses of 5 days). This drug induces rapid T-cell suppression within about 48 hours and has been safe, effective, and well-tolerated at these doses. In cases where sustained more potent immunosuppression is required for clinical stabilization, azathioprine (Imuran) should be instituted along with cyclosporine. Dose is 1 mg/lb/day for 7-10 days initially followed by a downward tapering over several weeks. Azathioprine may be needed every other day or less often, on a longterm basis. As azathioprine takes about 10 days to effectively suppress T-cells, clinical responsiveness will not occur immediately. Cyclosporine is therefore given concurrently in the early stages of the disease to provide rapid immunosuppression until the azathioprine takes hold.
The goal of this immunosuppressive therapy is to stabilize the ongoing immune destructive process. The dosage guideline we use is adjusted to maintain the absolute lymphocyte count as about 1/3 of the normal range (750-1500/ul).
4) Other immune suppressive drugs for refractory cases include: mycophenolate (Cell Cept), but we do NOT recommend leflunomide (Arava) as it can cause adverse effects on the liver.
5) Those breeds most often affected in our case population are cocker spaniels, poodles (all varieties), golden retrievers, Doberman pinschers, dachshunds, miniature schnauzers, akitas, beagles, rottweilers, Lhasa apsos, German shepherds, shih tzus, terriers, and mixed breeds of these backgrounds. Any of the nearly 50 breeds predisposed to thyroid disease are at risk for an immune-mediated condition. Thyroid supplementation at 0.1 mg/10lb given twice daily is essential for cases with concomitant thyroid disease and is helpful to stimulate the bone marrow whether or not thyroid tests indicate hypothyroidism. It also enhances platelet function.
6) Anabolic steroid (nandrolone decanoate, Deca Durabolin, 2-5 mg/kg given once a week or 4-6 doses) is given to stimulate the marrow.
7) Hematinics containing iron, folic acid, and vitamin B12 have been helpful. Meals should be small and often and grain-free ( no wheat, corn or soy) , so that his liver can handle the drugs and the food he needs. See attached homemade diet recipe. Liver cleansing herbs like milk thistle and SAMe may be advisable as well, if his liver enzymes become elevated.
8) In poorly responsive immune thrombocytopenias (ITP), an initial dose of vincristine (Oncovin, 0.01 mg/lb IV) may be helpful to release remaining platelet stores, and danazol (Danacrine, 2.5-5 mg/lb BID initially and then tapered to SID) has been effective along with steroids and thyroid for longterm maintenance.
9) The most severe cases with autoagglutinating red cells or profound thrombocytopenia may recover completely with the aggressive therapeutic approach outlined above, although a subset of these dogs convert to having a chronic low-grade nonresponsive anemia over the longterm.
10) Cases with the best overall prognosis tend to be younger animals in which the underlying primary “trigger” of the immune-mediated disease was hypothyroidism, a drug which is withdrawn, or a recent vaccination/toxic exposure. Correction of the thyroid disease with serial monitoring of thyroid function to establish the appropriate maintenance dose of hormonal supplement is important.